User:INN_Ingrid
Editor (rollback)·15,488 edits·since 2024/07
INN_Ingrid is an editor on PeptidePedia Wiki, editing since 2024 / 7.
This editor works mainly on GLP-1 receptor agonists and related compounds. Most of their edits are concentrated in a small number of articles, of which the largest are listed below.
Editing record
15,488Total edits
38Logged here
26Articles touched
2024/07Editing since
The record shown on this wiki covers the pages indexed in this editor's contributions. Their declared area of interest is GLP-1 receptor agonists and related compounds.
Most-edited pages
| Page | Edits by this editor | Total revisions | Share |
|---|---|---|---|
| Oral semaglutide | 2 | 30 | 7% |
| Intention-to-treat analysis | 2 | 26 | 8% |
| Timeline of incretin therapeutics | 2 | 30 | 7% |
| Tirzepatide | 1 | 37 | 3% |
| Lixisenatide | 1 | 26 | 4% |
| CagriSema | 1 | 31 | 3% |
| Peptide content | 1 | 33 | 3% |
| Shenzhen Hybio Pharmaceutical | 1 | 37 | 3% |
| Liraglutide | 1 | 37 | 3% |
| Placebo-adjusted effect | 1 | 28 | 4% |
| Melanotan II | 1 | 30 | 3% |
| Survodutide | 1 | 28 | 4% |
| Peptide supply chain | 1 | 39 | 3% |
| Sigma-Aldrich (Shanghai) Trading | 1 | 35 | 3% |
Awards
Disclosure
This editor declares no financial or professional relationship with any organisation covered by PeptidePedia Wiki. Editors who do have such a relationship are required to disclose it here under Project:Conflict of interest.